Venetoclax combined with hypomethylating agents induced tumor lysis syndrome in patients with acute leukemia: 7 cases report and literature review.
10.3760/cma.j.issn.0253-2727.2023.06.013
- Author:
Yu Sha GUO
1
;
Chen Hao ZHAO
2
;
De Yuan HU
1
;
Kai SHEN
1
;
Su Ning CHEN
3
Author Information
1. Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
2. Department of Clinical Laboratory, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
3. Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China Jiangsu Institute of Hematology, Suzhou 215006, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Tumor Lysis Syndrome/drug therapy*;
Leukemia, Myeloid, Acute/pathology*;
Bridged Bicyclo Compounds, Heterocyclic/therapeutic use*;
Sulfonamides/therapeutic use*;
Antineoplastic Combined Chemotherapy Protocols;
Antineoplastic Agents/therapeutic use*
- From:
Chinese Journal of Hematology
2023;44(6):508-511
- CountryChina
- Language:Chinese
